Filing Details
- Accession Number:
- 0001209191-21-002825
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-08 19:05:18
- Reporting Period:
- 2021-01-07
- Accepted Time:
- 2021-01-08 19:05:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603347 | Alan Theodore Huizenga | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Svp, Controller And Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-07 | 4,000 | $21.00 | 20,436 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 4,000 | $140.65 | 15,716 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-01-07 | 4,000 | $0.00 | 4,000 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2024-01-29 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.04 to $143.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes 214 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2020. Also reflects dispositions from gifts that will be reported in a Form 5 within 45 days after the Issuer's fiscal year end.
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.
Billionaire Hedge Funds
